The occurrence and proposed significance of schnabel cavernous degeneration in uveal melanoma

Mozhgan Rezaei Kanavi, Amir A. Azari, Heather D. Potter, Vivian Lee, Daniel Albert

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

OBJECTIVE To explore an association between SCD and UM. DESIGN, SETTING, AND PARTICIPANTS A historical cohort analysiswas performed using histologic slides and related clinical records of cases from the Collaborative Ocular Melanoma Study and Eye Pathology Laboratory at the University of Wisconsin, including 1985 UM eyes, 517 eye bank eyes, and 155 enucleated glaucomatous eyes. MAIN OUTCOMES AND MEASURES The prevalence of SCDwas calculated and compared between each group; subgroup analysis was also conducted of eyes with and without SCD for the prevalence of glaucoma. RESULTS Schnabel cavernous degeneration was seen in 17 (0.9%) UM eyes, 9 (1.7%) eye bank eyes, and 2 (1.3%) enucleated glaucomatous eyes. No difference was detected between the prevalence of SCD in UM eyes and eye bank eyes (odds ratio [OR], 0.49; 95%CI, 0.22-1.10) or enucleated glaucomatous eyes (OR, 0.66; 95%CI, 0.15-2.89). Subgroup analysis, performed on 421 UMeyes, provided sufficient clinical information to definitively establish the presence or absence of glaucoma. Of the 95 (22.6%) eyes with glaucoma, 11 (11.6%) revealed histopathologic evidence of SCD. Compared with enucleated end-stage glaucoma eyes, this represents a 10-fold increase in SCD in UM eyes with glaucoma (OR, 10.10; 95%CI, 2.17-46.26). The prevalence of glaucoma in UM eyes with SCD, however, was respectively 7- and 15-fold higher than the prevalence of glaucoma in SCD-negative UMeyes (OR, 6.98; 95% CI, 2.51-19.43) and SCD-positive eye bank eyes (OR, 14.67; 95%CI, 1.46-146.97). CONCLUSIONS AND RELEVANCE Although an association between SCD and UM was not confirmed, subgroup analysis did reveal an increased incidence of SCD in eyes with both UM and glaucoma. This suggests that the occurrence of glaucoma may increase the risk of SCD in eyes with UM.

Original languageEnglish (US)
Pages (from-to)600-604
Number of pages5
JournalJAMA ophthalmology
Volume132
Issue number5
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Glaucoma
Eye Banks
Odds Ratio
Uveal melanoma
Melanoma
Pathology
Incidence

ASJC Scopus subject areas

  • Ophthalmology

Cite this

The occurrence and proposed significance of schnabel cavernous degeneration in uveal melanoma. / Kanavi, Mozhgan Rezaei; Azari, Amir A.; Potter, Heather D.; Lee, Vivian; Albert, Daniel.

In: JAMA ophthalmology, Vol. 132, No. 5, 01.01.2014, p. 600-604.

Research output: Contribution to journalArticle

Kanavi, Mozhgan Rezaei ; Azari, Amir A. ; Potter, Heather D. ; Lee, Vivian ; Albert, Daniel. / The occurrence and proposed significance of schnabel cavernous degeneration in uveal melanoma. In: JAMA ophthalmology. 2014 ; Vol. 132, No. 5. pp. 600-604.
@article{67ffe543ad714a4db2cea67832c57340,
title = "The occurrence and proposed significance of schnabel cavernous degeneration in uveal melanoma",
abstract = "OBJECTIVE To explore an association between SCD and UM. DESIGN, SETTING, AND PARTICIPANTS A historical cohort analysiswas performed using histologic slides and related clinical records of cases from the Collaborative Ocular Melanoma Study and Eye Pathology Laboratory at the University of Wisconsin, including 1985 UM eyes, 517 eye bank eyes, and 155 enucleated glaucomatous eyes. MAIN OUTCOMES AND MEASURES The prevalence of SCDwas calculated and compared between each group; subgroup analysis was also conducted of eyes with and without SCD for the prevalence of glaucoma. RESULTS Schnabel cavernous degeneration was seen in 17 (0.9{\%}) UM eyes, 9 (1.7{\%}) eye bank eyes, and 2 (1.3{\%}) enucleated glaucomatous eyes. No difference was detected between the prevalence of SCD in UM eyes and eye bank eyes (odds ratio [OR], 0.49; 95{\%}CI, 0.22-1.10) or enucleated glaucomatous eyes (OR, 0.66; 95{\%}CI, 0.15-2.89). Subgroup analysis, performed on 421 UMeyes, provided sufficient clinical information to definitively establish the presence or absence of glaucoma. Of the 95 (22.6{\%}) eyes with glaucoma, 11 (11.6{\%}) revealed histopathologic evidence of SCD. Compared with enucleated end-stage glaucoma eyes, this represents a 10-fold increase in SCD in UM eyes with glaucoma (OR, 10.10; 95{\%}CI, 2.17-46.26). The prevalence of glaucoma in UM eyes with SCD, however, was respectively 7- and 15-fold higher than the prevalence of glaucoma in SCD-negative UMeyes (OR, 6.98; 95{\%} CI, 2.51-19.43) and SCD-positive eye bank eyes (OR, 14.67; 95{\%}CI, 1.46-146.97). CONCLUSIONS AND RELEVANCE Although an association between SCD and UM was not confirmed, subgroup analysis did reveal an increased incidence of SCD in eyes with both UM and glaucoma. This suggests that the occurrence of glaucoma may increase the risk of SCD in eyes with UM.",
author = "Kanavi, {Mozhgan Rezaei} and Azari, {Amir A.} and Potter, {Heather D.} and Vivian Lee and Daniel Albert",
year = "2014",
month = "1",
day = "1",
doi = "10.1001/jamaophthalmol.2013.8182",
language = "English (US)",
volume = "132",
pages = "600--604",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - The occurrence and proposed significance of schnabel cavernous degeneration in uveal melanoma

AU - Kanavi, Mozhgan Rezaei

AU - Azari, Amir A.

AU - Potter, Heather D.

AU - Lee, Vivian

AU - Albert, Daniel

PY - 2014/1/1

Y1 - 2014/1/1

N2 - OBJECTIVE To explore an association between SCD and UM. DESIGN, SETTING, AND PARTICIPANTS A historical cohort analysiswas performed using histologic slides and related clinical records of cases from the Collaborative Ocular Melanoma Study and Eye Pathology Laboratory at the University of Wisconsin, including 1985 UM eyes, 517 eye bank eyes, and 155 enucleated glaucomatous eyes. MAIN OUTCOMES AND MEASURES The prevalence of SCDwas calculated and compared between each group; subgroup analysis was also conducted of eyes with and without SCD for the prevalence of glaucoma. RESULTS Schnabel cavernous degeneration was seen in 17 (0.9%) UM eyes, 9 (1.7%) eye bank eyes, and 2 (1.3%) enucleated glaucomatous eyes. No difference was detected between the prevalence of SCD in UM eyes and eye bank eyes (odds ratio [OR], 0.49; 95%CI, 0.22-1.10) or enucleated glaucomatous eyes (OR, 0.66; 95%CI, 0.15-2.89). Subgroup analysis, performed on 421 UMeyes, provided sufficient clinical information to definitively establish the presence or absence of glaucoma. Of the 95 (22.6%) eyes with glaucoma, 11 (11.6%) revealed histopathologic evidence of SCD. Compared with enucleated end-stage glaucoma eyes, this represents a 10-fold increase in SCD in UM eyes with glaucoma (OR, 10.10; 95%CI, 2.17-46.26). The prevalence of glaucoma in UM eyes with SCD, however, was respectively 7- and 15-fold higher than the prevalence of glaucoma in SCD-negative UMeyes (OR, 6.98; 95% CI, 2.51-19.43) and SCD-positive eye bank eyes (OR, 14.67; 95%CI, 1.46-146.97). CONCLUSIONS AND RELEVANCE Although an association between SCD and UM was not confirmed, subgroup analysis did reveal an increased incidence of SCD in eyes with both UM and glaucoma. This suggests that the occurrence of glaucoma may increase the risk of SCD in eyes with UM.

AB - OBJECTIVE To explore an association between SCD and UM. DESIGN, SETTING, AND PARTICIPANTS A historical cohort analysiswas performed using histologic slides and related clinical records of cases from the Collaborative Ocular Melanoma Study and Eye Pathology Laboratory at the University of Wisconsin, including 1985 UM eyes, 517 eye bank eyes, and 155 enucleated glaucomatous eyes. MAIN OUTCOMES AND MEASURES The prevalence of SCDwas calculated and compared between each group; subgroup analysis was also conducted of eyes with and without SCD for the prevalence of glaucoma. RESULTS Schnabel cavernous degeneration was seen in 17 (0.9%) UM eyes, 9 (1.7%) eye bank eyes, and 2 (1.3%) enucleated glaucomatous eyes. No difference was detected between the prevalence of SCD in UM eyes and eye bank eyes (odds ratio [OR], 0.49; 95%CI, 0.22-1.10) or enucleated glaucomatous eyes (OR, 0.66; 95%CI, 0.15-2.89). Subgroup analysis, performed on 421 UMeyes, provided sufficient clinical information to definitively establish the presence or absence of glaucoma. Of the 95 (22.6%) eyes with glaucoma, 11 (11.6%) revealed histopathologic evidence of SCD. Compared with enucleated end-stage glaucoma eyes, this represents a 10-fold increase in SCD in UM eyes with glaucoma (OR, 10.10; 95%CI, 2.17-46.26). The prevalence of glaucoma in UM eyes with SCD, however, was respectively 7- and 15-fold higher than the prevalence of glaucoma in SCD-negative UMeyes (OR, 6.98; 95% CI, 2.51-19.43) and SCD-positive eye bank eyes (OR, 14.67; 95%CI, 1.46-146.97). CONCLUSIONS AND RELEVANCE Although an association between SCD and UM was not confirmed, subgroup analysis did reveal an increased incidence of SCD in eyes with both UM and glaucoma. This suggests that the occurrence of glaucoma may increase the risk of SCD in eyes with UM.

UR - http://www.scopus.com/inward/record.url?scp=84900405566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900405566&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2013.8182

DO - 10.1001/jamaophthalmol.2013.8182

M3 - Article

C2 - 24652500

AN - SCOPUS:84900405566

VL - 132

SP - 600

EP - 604

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 5

ER -